Practical guide for the treatment of leishmaniasis

Drugs

Volumn 56, Issue 6, 1998, Pages 1009-1018

  Davidson, Robert N ^a  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIMONY DERIVATIVE; PAROMOMYCIN; PENTAMIDINE;

CLINICAL FEATURE; DRUG CHOICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; LEISHMANIASIS; REVIEW; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIPROTOZOAL AGENTS; HUMANS; IMMUNOCOMPROMISED HOST; INTERFERON TYPE II; LEISHMANIASIS; PSYCHODIDAE;

EID: 0032438513     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199856060-00005     Document Type: Review

References (37)

1. Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997; 24: 684-703
2. Remme JH, De Raadt P, Godal T. The burden of tropical diseases. Med J Aust 1993; 158: 465-9
3. WHO. Control of the leishmaniases -report of a WHO Expert Committee. Tech Rep Series 793. Geneva: WHO, 1990
4. Bogdan C, Gessner A, Solbach A, et al. Invasion, control, and persistence of Leishmania parasites. Curr Opin Immunol 1996; 8: 517-25
5. Bryceson A. Therapy in man. In: Peters W, Killick-Kendrick R. editors. The leishmaniases in biology and medicine. Vol II: clinical aspects and control. London: Academic Press. 1987: 847-95
6. Herwaldt BL; Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992; 46: 296-306
7. Franco MA, Barbosa AC, Rath S, et al. Antimony oxidation states in antileishmanial drugs. Am J Trop Med Hyg 1995 May; 52 (5): 435-7
8. Berman JD, Edwards N, King M, et al. Biochemistry of Pentostam resistant Leishmania. Am J Trop Med Hyg 1984; 40: 159-64
9. Gramiccia M, Gradoni L. Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of treatment. Ann Trop Med Parasitol 1992; 86: 613-20
10. Neal RA, van Bueren J, McCoy NG, et al. Reversal of drug resistance in Trypanosoma crcio and Leishmania donovani by verapamil. Trans R Soc Trop Med Hyg 1989 Mar-Apr; 83 (2): 197-8
11. Thakur CP, Kumar M. Observations on the effect of verapamil with sodium stibogluconate in kala azar. Trop Geogr Med 1942; 44: 15-8
12. Chulay JD, Fleckenstein L, Smith DH. Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate. Trans R Soc Trop Med Hyg 1988; 82 (1): 69-72
13. Al Jaser MA, el Yazigi A, Croft SL. Pharmacokinetics of antimony in patients treated with sodium stibogluconate for cutaneous leishmaniasis. Pharm Res 1995; 12: 113-6
14. McBride MO, Linney M, Davidson RN, et al. Pancreatic necrosis following treatment of leishmaniasis with sodium stibogluconate. Clin Infect Dis 1995 Sep; 21 (3): 710
15. Sundar S, Sinha PR, Agrawal NDK, et al. A cluster of cases of severe cardiotoxicity among kala azar patients treated with a high osmolarity lot of sodium antimony gluconate. Am J Trop Med Hyg 1998 Jul; 59 (1): 139-43
16. Gasser Jr RA. Magill AJ, Oster CN, et al. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis. Clin Infect Dis 1994 Jan; 18 (1): 83-90
17. Navin TR, Arana BA, Arana FE, et al. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis 1992 Mar; 163 (3): 528-34
18. Hepburn NC, Nolan J, Fenn L, et al. Cardiac effects of sodium stibogluconate: myocardial, electrophysiological and biochemical studies. Q J Med 1994 Aug; 87 (8): 465-72
19. Thakur CP, Sinha GP, Pandey AK. Comparison of regimens of amphotericin B deoxycholate in kala-azar. Indian J Med Res 1996; 103: 259-63
20. Thakur CP, Narain S, Kumar N, et al. Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-azar dermal leishmaniasis. Ann Trop Med Parasitol 1997; 91: 611-6
21. De Marie S, Janknegt, Bakker-Woudenberg IA. Clinical use of liposomal and lipid-complexed amphotericin B. J Antimicrob Chemother 1994; 33 (5): 907-16
22. Thakur CP, Pandey AK, Sinha GP, et al. Comparison of three treatment regimens with liposomal amphoteriein B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study. Trans R Soc Trop Med Hyg 1996; 90: 319-22
23. Davidson RN, di Martino L, Gradoni L, et al. Short course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome). Clin Infect Dis 1996; 22: 938-43
24. Baily GG, Pitt MA, Curry A, et al. Leishmaniasis of the tongue treated with liposomal amphotericin B. J Infect 1994; 28: 327-31
25. Nonata R, Sampaio R, Marsden PD. Mucosal leishmaniasis un responsive to glucantime therapy successfully treated with AmBisome. Trans R Soc Trop Med Hyg 1997; 91: 77
26. Sundar S, Agrawal NK, Sinha PR, et al. Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony. Ann Intern Med 1997; 127: 133-7
27. Jha TK, Olliaro P, Thakur CPN, et al. Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India. BMJ 1998; 316: 1200-5
28. Sundar S, Singh VP, Sharma S, et al. Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis. J Infect Dis 1997; 176: 1117-9
29. Badaro R, Nascimento C, Carvalho JS, et al. Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis. J Infect Dis 1994; 170(2): 413-8
30. Dogra J, Saxena VN. Itraconazole and leishmaniasis: a randomised double-blind trial in cutaneous disease. Int J Parasitol 1996; 26: 1413-5
31. Llanos-Cuentas A, Echevarria J, Cruz M, et al. Efficacy of sodium stibogluconate alone and in combination with allopurinol for treatment of mucocutaneous leishmaniasis. Clin Infect Dis 1997; 25: 677-84
32. Soto J, Fuya P, Herrera R, et al. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study. Clin Infect Dis 1998; 26: 56-8
33. Sundar S, Reed SG, Singh VP, et al. Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet 1997; 351: 563-5
34. Magill AJ, Grogl M, Gasser RA, et al. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 1993; 328: 1383-7
35. Davidson RN. AIDS and leishmaniasis. Genitourin Med 1997; 73: 237-9
36. Gradoni L, Scalone A, Grammiccia M, et al. Epidemiological surveillance of leishmaniasis HIV-1-infected individuals in Italy. AIDS 1996; 10: 785-91
37. Valasco-Castrejon O, Walton BC, Rivas-Sanchez, et al. Treatment of cutaneous leishmaniasis with localized current field (radiofrequency) in Tabasco, Mexico. Am J Trop Med Hyg 1997; 57 (3): 309-12